BioCentury
ARTICLE | Company News

GlaxoSmithKline sales and marketing update

June 12, 2006 7:00 AM UTC

GSK will lower the not-for-profit price of four of its 11 HIV antiretrovirals. Trizivir's price will drop 31% to $70 from $102. The prices of Ziagen tablets and oral solution went down 28% to $52.29...